FDA Investigator Arlene M Badillo

Arlene M Badillo has conducted inspections on 74 sites in 5 countries as of 26 Mar 2007. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
74
Last Inspection Date:
26 Mar 2007
Investigator Role:
FDA Investigator
Redica ID:
100000368
Countries of Inspections:
Italy, Puerto Rico, Sweden, Spain, Canada
FDA Investigators that have inspected at least one site in common with Arlene M Badillo:
Adalberto Cajigas, Adaliz Santaliz Cruz, Alan A Rivera, Alicia M Mozzachio, Alonso, An T Vu, Ana M Rivera, Ana P Barido, Anabel Veiga, Anastasia M Shields, Andrea George, PhD, Angelica M Hernandez, Anita R Michael, Ariel Cruz Figueroa, Arsen Karapetyan, Arwa S El Hagrasy, Ashley N Queen, PhD, Binh T Nguyen, Brenda Rivera, Calvin B Koerner, Carla J Lundi, Carlos A Medina, Carmelo Ross, Carrie A Hughes, Cassandra L Abellard, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Cheryl A Clausen, Christina Capacci Daniel, PhD, Christopher Downey, PhD, Christopher T Middendorf, Colleen F Hoyt, Colleen Thomas, PhD, Cynthia A Palmer, Cynthia J Lee, MS, Daniel L Obrzut, Daryl A Dewoskin, David J Hafner, Dayna I Martinez, Dennis Cantellops Paite, Don H Bark, PhD, Donald C Obenhuber, PhD, Donna Christner, Dov H Pluznik, PhD, Dr. Carmelo Rosa, Dr. Zhihao Qiu (Peter), PhD, Edwin Martinez, Eliezar Ramos, Enrique Galan, Erika V Butler, Farhana Khan, Felix Maldonado, Frances L Dejesus, Frederick L Fricke, Geraldine D Sanders, German Rivera, Hector Espinet, Heika R Tait, Iraida Ortiz, Israel Santiago, OCM, Ivis L Negron, Ivonne A Vicente, Jaime E Pares, James M Mason, Javier O Vega, Jennifer Lalama, Jerri Baker, Joan M Cantellops Figueroa, Joe X Phillips, Jorge E Martinez, Jorge L Gonzalez, Jorge L Guadalupe, Jorge L Lajara, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, José E Meléndez, Jose F Pedro, Jose Perez Soto, Jose R Lopez, Jose Rflores Veguilla, Jose Velez, Juan Rjimenez Garcia, Karl D Hezel, Keishla M Arroyo Lopez, Kham Phommachanh, Krishna Ghosh, PhD, Laiza V Garcia, Lareese K Thomas, Laura E Garcia, Laurimer Kuilan Torres, Leonard H Lavi, Libia M Lugo, Lisa M Lopez, Loreily Figueroa Agrinsoni, Lourdes Andujar, LT Luis O Rodriguez, LT Rafael Gonzalez, Luis A Carrion, Margarita Santiago, Maria A Ruttell, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marianela Aponte Cruz, Maribel V Juarbe, Maricelys Mercado, Maridalia Torres Irizarry, Marie A Fadden, Marie T Falcone, Marilyn Santiago, Marisol Faberlle, Marta E Gonzalez, Maxwell Van Tassell, PhD, Medina, Michael A Charles, Michael Levy, Michael R Klapal, Michael Shanks, MS, Michelle Yclark Stuart, Miguel A Martinez Perez, Milva E Melendez Perales, Monica Cburgos Garcia, Moraima Jramos Valle, Mra Greenc, Mra Mcculloughj, Myriam M Sosa, Nancy Rosado, Neisa M Alonso, Nicholas Obiri, PhD, Nikolay Spiridonov, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Pablo Feliciano, Patricia F Hughes, PhD, Paul Z Balcer, Paula A Trost, Peter C Chow, Prabhu P Raju, Rafael E Arroyo, Rafael Nevarez Nieves, Ramesh Potla, PhD, Ramon A Hernandez, Rapti D Madurawe, Raquel Gonzalez Rivera, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Riley C Myers, PhD, Robert Darius, Robert Jennings, Rosa J Motta, Russell K Riley, Samina S Khan, Sharmista Chatterjee, Sixto M Mercado Rios, Sonia M Monges, Stacie A Woods, Stephanie D Crockett, Steven B Barber, Steven C Madzo, Steven D Kehoe, Steven Fong, MS, PhD, Tajah L Blackburn, Teresa Jimenez, Thomas J Arista, Tiara Nbrown Crosen, Timothy T Kapsala, Timothy Wadkin, PhD, Vilmary Negron Rodriguez, Vlada Matusovsky, Wanda J Torres, Wendy G Tan, PhD, Yifan Wang, Ying Zhang, Youmin Wang, Zachary L Stamm, Zhong Li, PhD

Arlene M Badillo's Documents

Publish Date Document Type Title
April, 2002 EIR Medichem SA - EIR, 2002-04-18
March, 2001 EIR Lilly del Caribe, Inc. - EIR, 2001-03-08
November, 2005 FDA 483 Pfizer Pharmaceuticals LLC - Form 483, 2005-11-22
September, 2003 FDA 483 Flamma SpA - Form 483, 2003-09-17
June, 2001 FDA 483 Response MSD International GmbH (Puerto Rico Branch) LLC - Form 483R, 2001-06-18
April, 2002 FDA 483 Response Medichem SA - Form 483R, 2002-08-02
August, 2001 EIR Pfizer Pharmaceuticals LLC - EIR, 2001-08-08
September, 2003 FDA 483 Response Flamma SpA - Form 483R, 2003-09-26
June, 2000 FDA 483 Baxter Healthcare Corporation - Form 483, 2000-06-09
September, 2001 FDA 483 Response Taro Pharmaceuticals Inc. - Form 483R, 2001-11-19
August, 2000 FDA 483 Pan American Grain Manufacturing Company, Inc. - Form 483, 2000-08-30
October, 2000 EIR Wyeth Parenterals Divison of Wyeth Holdings Corp. - EIR, 2000-10-26
June, 2000 EIR Baxter Healthcare Corporation - EIR, 2000-06-09
September, 2003 EIR Curia Italy S.r.l. - EIR, 2003-09-25
April, 2002 EIR DSM Anti-Infectives - EIR, 2002-04-29
July, 2001 FDA 483 Response Pfizer Pharmaceuticals LLC - Form 483R, 2001-07-27
December, 2001 FDA 483 Janssen Ortho LLC - Form 483, 2001-11-29
July, 2001 FDA 483 Pfizer Pharmaceuticals LLC - Form 483, 2001-07-12
January, 2000 FDA 483 Surgical Specialties Puerto Rico, Inc. dba Angiotech, PR - Form 483, 2000-01-27
March, 2001 FDA 483 Lilly del Caribe, Inc. - Form 483, 2001-03-08
March, 2001 FDA 483 Response Lilly del Caribe, Inc. - Form 483R, 2001-03-23
December, 2003 FDA 483 Ivax Pharmaceuticals, Inc. - Form 483, 2003-12-19
April, 2002 FDA 483 SSRI Anti-Injectives Sweden A.B. - Form 483, 2002-04-29
June, 2006 FDA 483 Ivax Pharmaceuticals, Inc. - Form 483, 2006-06-02
June, 2001 EIR MSD International GmbH (Puerto Rico Branch) LLC - EIR, 2001-06-05
September, 2000 FDA 483 Baxter Healthcare Corporation - Form 483, 2000-09-29
October, 2002 EIR Smithkline Beecham (Cork) Inc. - EIR, 2002-10-09
March, 2007 FDA 483 Auro PR Inc. - Form 483, 2007-03-02
August, 2003 EIR Schering Plough Products, LLC - EIR, 2003-08-22
August, 2002 EIR Baxter Healthcare Corporation - EIR, 2002-08-23
August, 2000 EIR Pan American Grain Company Inc. - EIR, 2000-08-30
September, 2006 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2006-09-28
December, 2003 EIR Ivax Pharmaceuticals, Inc. - EIR, 2003-12-19
September, 2001 EIR Taro Pharmaceuticals Inc. - EIR, 2001-10-24
January, 2000 EIR Surgical Specialties Puerto Rico, Inc. dba Angiotech, PR - EIR, 2000-01-27
October, 2004 EIR MSD International GmbH (Puerto Rico Branch) LLC - EIR, 2004-10-15
April, 2002 FDA 483 Response DSM Anti-Infectives - Form 483R, 2002-05-22
July, 2001 EIR Pfizer Pharmaceuticals LLC - EIR, 2001-07-12
March, 2002 EIR Janssen Ortho LLC - EIR, 2002-03-18
January, 2001 EIR Cardinal Health Manufacturing Services B.V. - EIR, 2001-01-18
August, 2001 FDA 483 Pfizer Pharmaceuticals LLC - Form 483, 2001-08-08
December, 2002 FDA 483 ADM Alliance Nutrition of Puerto Rico, LLC - Form 483, 2002-12-10
May, 2004 EIR Cardinal Health Manufacturing Services B.V. - EIR, 2004-05-27
September, 2003 FDA 483 Poli Industria Chimica S.p.A. - Form 483, 2003-09-25
April, 2000 FDA 483 Wyeth Pharmaceuticals Company - Form 483, 2000-04-27
January, 2004 FDA 483 Ortho Biologics LLC - Form 483, 2004-01-20
August, 2003 FDA 483 Schering-Plough Products LLC - Form 483, 2003-08-22
May, 2004 FDA 483 Cardinal Health Manufacturing Services B.V. - Form 483, 2004-06-22
October, 2002 FDA 483 Smithkline Beecham (Cork) Inc. - Form 483, 2002-10-09
August, 2000 EIR ADM Alliance Nutrition of Puerto Rico, LLC - EIR, 2000-08-02
March, 2003 EIR Boehringer Ingelheim Animal Health Puerto Rico LLC - EIR, 2003-03-07
September, 2003 EIR Flamma SpA - EIR, 2003-09-17
January, 2004 EIR Ortho Biologics LLC - EIR, 2004-01-20
September, 2003 FDA 483 Response Curia Italy S.r.l. - Form 483R, 2003-10-14
August, 2000 FDA 483 ADM Alliance Nutrition of Puerto Rico, LLC - Form 483, 2000-08-02
December, 2001 EIR Janssen Ortho LLC - EIR, 2001-12-17
June, 2001 FDA 483 Schering-Plough Products L.L.C. - Form 483, 2001-06-05
March, 2003 FDA 483 Response Boehringer Ingelheim Animal Health Puerto Rico LLC - Form 483R, 2003-03-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more